We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSAT icon
5326
Globalstar
GSAT
$10.9B
$286K ﹤0.01%
36,677
-2,173
-6% -$13.1K
RCKY icon
5327
Rocky Brands
RCKY
$364M
$286K ﹤0.01%
9,710
+3,809
+65% +$112K
APLS
5328
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$285K ﹤0.01%
+9,300
New +$257K
DLTH icon
5329
Duluth Holdings
DLTH
$151M
$285K ﹤0.01%
27,091
+7,844
+41% +$73.1K
LFVN icon
5330
LifeVantage
LFVN
$84.3M
$285K ﹤0.01%
18,287
+4,727
+35% +$69.5K
WMB icon
5331
CALL
Williams Companies
WMB
$87.9B
$285K ﹤0.01%
12,000
-97,500
-89% -$2.23M
GNC
5332
DELISTED
GNC Holdings, Inc.
GNC
$284K ﹤0.01%
105,314
+7,139
+7% +$19.1K
APRE icon
5333
Aprea Therapeutics
APRE
$7.98M
$283K ﹤0.01%
+308
New +$170K
PEBK icon
5334
Peoples Bancorp of North Carolina
PEBK
$228M
$283K ﹤0.01%
8,596
+3,529
+70% +$108K
APD icon
5335
PUT
Air Products & Chemicals
APD
$68.6B
$282K ﹤0.01%
1,200
+900
+300% +$203K
ANDAU
5336
DELISTED
Andina Acquisition Corp. III Unit
ANDAU
$282K ﹤0.01%
26,700
-1,150
-4% -$12.1K
FBIZ icon
5337
First Business Financial Services
FBIZ
$589M
$281K ﹤0.01%
10,676
+4,455
+72% +$110K
NMT icon
5338
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$129M
$281K ﹤0.01%
19,731
-2,345
-11% -$33.1K
SOXL icon
5339
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$22.2B
$281K ﹤0.01%
15,345
+765
+5% +$11.1K
JPGE
5340
DELISTED
JPMorgan Diversified Return Global Equity ETF
JPGE
$281K ﹤0.01%
4,528
-1,228
-21% -$74.7K
POPE
5341
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$281K ﹤0.01%
3,040
-364
-11% -$30.1K
AUDC icon
5342
AudioCodes
AUDC
$255M
$280K ﹤0.01%
10,906
+4,378
+67% +$95.8K
NIM icon
5343
Nuveen Select Maturities Municipal Fund
NIM
$116M
$280K ﹤0.01%
26,704
+12,374
+86% +$129K
APLT
5344
DELISTED
Applied Therapeutics
APLT
$279K ﹤0.01%
10,225
+6,482
+173% +$111K
BIZD icon
5345
VanEck BDC Income ETF
BIZD
$1.68B
$279K ﹤0.01%
16,678
+2,213
+15% +$36.7K
FVCB icon
5346
FVCBankcorp
FVCB
$333M
$278K ﹤0.01%
19,874
+7,244
+57% +$100K
USMF icon
5347
WisdomTree US Multifactor Fund
USMF
$303M
$278K ﹤0.01%
8,696
-3,767
-30% -$117K
SLCT
5348
DELISTED
Select Bancorp, Inc.
SLCT
$278K ﹤0.01%
22,583
+8,012
+55% +$94.2K
ENOR icon
5349
iShares MSCI Norway ETF
ENOR
$100M
$277K ﹤0.01%
10,977
+3,515
+47% +$83.3K
NTRA icon
5350
Natera
NTRA
$45.9B
$277K ﹤0.01%
8,226
-159,254
-95% -$5.87M

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.